JP Morgan Chase’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Hold
0
7564
2024
Q1
Sell
-3
Closed -$13.1K 7638
2023
Q4
$24.8K Buy
3
+1
+50% +$13.7K ﹤0.01% 6199
2023
Q3
$22.2K Buy
+2
New +$43.9K ﹤0.01% 6046
2023
Q2
Hold
0
6026
2023
Q1
Hold
0
6523
2022
Q4
Hold
0
6316
2022
Q3
Hold
0
6029
2022
Q2
Hold
0
5952
2022
Q1
Hold
0
6127
2021
Q4
Hold
0
5708
2021
Q1
Hold
0
6198
2020
Q4
Hold
0
5773

Other funds holding JAGX

JP Morgan Chase's JAGX Position: Q2 2024 in Review

JP Morgan Chase held its Jaguar Health (JAGX) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7564.

JP Morgan Chase first reported a position in JAGX in Q3 2023 and has held it in 2 quarters since. The position peaked at $24.8K in Q4 2023. 6 funds tracked by Wall St. Rank hold JAGX as of Q2 2024.

  • JP Morgan Chase held 0 shares of Jaguar Health worth $0 as of Q2 2024.
  • JP Morgan Chase left its Jaguar Health share count unchanged in Q2 2024.
  • Jaguar Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2024, its #7564 holding.
  • JP Morgan Chase first reported a position in Jaguar Health in Q3 2023 and has held it in 2 quarters since.
  • JP Morgan Chase's Jaguar Health position peaked at $24.8K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.